Strategic Family Wealth Counselors, L.L.C.
Position in AVXL — Anavex Life Sciences Corp.
CIK 1729755
FAIRFIELD, NJ
Position in AVXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,836
-$3,862 QoQ
Shares Held
8,045
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#128
of 179 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Jun 30, 2026CallValue
$15,540
CallShares
6,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Strategic Family Wealth Counselors, L.L.C. holds $39,428 across 2 Biotechnology names. AVXL ranks #1 (52.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
This page
|
8,045 | $20,836 | |
| 2 | MIST |
Milestone Pharmaceuticals Inc.
|
13,875 | $18,592 |
All Filings in AVXL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,540 | 6,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $20,836 | 8,045 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $33,770 | 11,000 | Call | Sole | 2026-05-11 | |
| 2026-03-31 | $24,698 | 8,045 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $67,150 | 7,545 | Shares | Sole | 2025-11-10 | |
| 2025-09-30 | $62,300 | 7,000 | Call | Sole | 2025-11-10 | |
| 2025-06-30 | $69,564 | 7,545 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $64,540 | 7,000 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $25,740 | 3,000 | Call | Sole | 2025-05-08 | |
| 2025-03-31 | $64,504 | 7,518 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||